The development of cell and gene therapy requires a complex supply chain which has started to emerge in Australia. Southern RNA contributes to this local supply chain by providing high quality reagent and CDMO service such as pDNA and mRNA process development, manufacturing, and quality control.

Participants will learn about:

• Introduction to Advance Therapy Medicinal Product (ATMP - which includes cell and gene therapy) and how pDNA and mRNA play an important role in the supply chain of ATMPs
• Overview of the pDNA and mRNA platform process developed by Southern RNA
• Overview of the collaboration with Eppendorf in upstream process development
• Quality control requirements and overview of Southern RNA QC platform ensuring the quality of pDNA and mRNA.